Liver mass surgery

Liver Mass Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differential Diagnosis
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Evaluation of Liver Mass
Staging
History and Symptoms
Physical Examination
Laboratory Studies
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Case Studies
Case #1
Liver mass surgery On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Liver mass surgery All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Liver mass surgery
CDC on Liver mass surgery
Liver mass surgery in the news
Blogs on Liver mass surgery
Directions to Hospitals Treating bone or soft tissue mass
Risk calculators and risk factors for Liver mass surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Surgery

 In the majority of cases of benign hepatic tumors, patients are asymptomatic, and no treatment is indicated. The main indication for treatment is the presence of significant clinical symptoms or suspicion of malignancy or fear of malignant transformation. Surgery is the mainstay of treatment for benign liver lesions. Management of lesions also depends upon:

• Symptoms
• Size
• Number
• Location
• Certainty of the diagnosis

Surgical options

• Embolization
• ERCP
• Liver resection
• Liver transplantation

Indications for Surgery

• Bleeding tumor
• Solitary Symptomatic Tumors

	Asymptomatic	Symptomatic
		Surgical		Non-Surgical options
		Indications	Options
Hepatic adenoma	The European Association for Study of the Liver recommends Discontinuation of contraceptive medication Close observation of the lesion with repeated imaging and alpha fetoprotein. Contrast-enhanced MRI at a six 6 month interval to determine if there is regression.	Symptomatic patients Large lesions (>5 cm).	Enucleation Resection Liver transplantation	Transarterial embolization Radiofrequency ablation
Hepatic Hemangioma	Patients with lesions <1.5 cm Reassurance Observation Patients with a rapid growth of a hemangioma or with lesions >5 cm Repeat imaging in 6 to 12 months.	Abdominal pain Symptoms suggestive of extrinsic compression of adjacent structures	Liver resection Enucleation Hepatic artery ligation Liver transplantation	Hepatic artery embolization Radiotherapy Interferon alfa-2a
Focal nodular hyperplasia	No indication for therapy unless they are symptomatic. Follow-up imaging studies 3-6 months will often be sufficient to confirm the stability of the lesion	N/A	N/A	N/A
Simple Hepatic cyst	No treatment Cysts >4 cms in diameter Periodic USG 3 months after initial diagnosis 6-12 months follow up If cyst remained stable no further treatment/followup	Abdominal pain Growing cyst	Needle aspiration with or without injection of sclerosing agents Internal drainage with cystojejunostomy Wide unroofing/cyst resection Liver resection
Non-Invasive Cystadenoma	Surgery High potential of malignant transformation	N/A	Removal of the cyst Partial excision Complete excision Aspiration Hepatic resection Considered whenever a cystic lesion is suspected of containing invasive carcinoma	N/A
Invasive cystadenoma	N/A	N/A	Liver resection	Radiation Chemotherapy
Hepatic abscess	N/A	Percutaneous  Abscess size is more than 5 cm Surgical drainage Ruptured abscess Hyperbilirubinemia or renal impairement Multiple and loculated abscesses which cannot be easily accessible by percutaneous drainage Inadequate drainage through percutaneous methods ERCP Bile duct stones  Strictures	Percutaneous Drainage Surgical Drainage ERCP